L. Czirják

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

M. Vonk, R. Naden, Y. Allanore, 2013, Arthritis and rheumatism.

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.

Y. Allanore, C. Stagnaro, M. Truchetet, 2023, The Lancet. Rheumatology.

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

F. Mendoza, J. D. de Vries-Bouwstra, M. Cerinic, 2020, Arthritis Research & Therapy.

Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort

J. D. de Vries-Bouwstra, J. Ciaffi, A. Balbir Gurman, 2024, RMD open.

Skin involvement in systemic sclerosis.

U. Müller-Ladner, L. Czirják, I. Foeldvari, 2008, Rheumatology.